Analysis Suggests Wider Use for PARP Inhibitors.
Sign Up to like & getrecommendations! Published in 2017 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-nb2017-049
Abstract: Researchers have developed a new tool, HRDetect, to pinpoint tumors that display BRCA deficiency but don't harbor BRCA1/2 mutations. Evaluating their method in breast, ovarian, and pancreatic cancers, they identified patients whose tumors were potentially… read more here.
Keywords: parp inhibitors; use parp; wider use; analysis suggests ... See more keywords